Molecular regulatory mechanism of ferroptosis and its role in gastrointestinal oncology:Progress and updates

Gastrointestinal(GI)tumors,including liver,pancreatic,gastric,and colorectal cancers,have a high incidence rate and low survival rate due to the lack of effective therapeutic methods and frequent relapses.Surgery and postoperative chemoradiotherapy have largely reduced the fatality rates for most GI tumors,but these therapeutic approaches result in poor prognoses due to severe adverse reactions and the development of drug resistance.Recent studies have shown that ferroptosis plays an important role in the onset and progression of GI tumors.Ferroptosis is a new non-apoptotic form of cell death,which is iron-dependent,non-apoptotic cell death characterized by the accumulation of lipid reactive oxygen species(ROS).The activation of ferroptosis can lead to tumor cell death.Thus,regulating ferroptosis in tumor cells may become a new therapeutic approach for tumors,making it become a research hotspot.Current studies suggest that ferroptosis is mainly triggered by the accumulation of lipid ROS.Furthermore,several studies have indicated that ferroptosis may be a new approach for the treatment of GI tumors.Here,we review current research progress on the mechanism of ferroptosis,current inducers and inhibitors of ferroptosis,and the role of ferroptosis in GI tumors to propose new methods for the treatment of such tumors.